• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 207/34 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 207/34

Total number of patents in this class: 594

10-year publication summary

39
29
26
30
37
46
29
34
21
13
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Takeda Pharmaceutical Company Limited
2703
17
Daiichi Sankyo Company, Limited
1849
17
Sunshine Lake Pharma Co., Ltd.
585
14
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
687
12
Viatris Specialty LLC
159
11
Syngenta Participations AG
1927
9
Syngenta Crop Protection AG
6013
8
Theravance Biopharma R&D IP, LLC
462
8
Bayer Cropscience SA
42
7
Activesite Pharmaceuticals, Inc.
18
7
AstraZeneca AB
2928
6
FUJIFILM Corporation
29188
6
Astellas Pharma Inc.
1083
6
Emory University
1619
6
Global Blood Therapeutics, Inc.
183
6
Kissei Pharmaceutical Co., Ltd.
184
6
New York Blood Center, Inc.
159
6
VenatoRx Pharmaceuticals, Inc.
84
6
Janssen Pharmaceutica N.V.
3431
5
Bayer Cropscience AG
2074
5
Other owners 426